MedTrace Logo

Diagnostic Value of Fecal Calprotectin in Disorders of the Upper Gastrointestinal Tract

NCT00920400 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 287

Last updated 2010-01-12

No results posted yet for this study

Summary

Fecal calprotectin is a very sensitive non-invasive inflammation marker in the detection of inflammatory bowel disease and, to a lesser degree, has also proven to be useful in adenomatous polyps, neoplasias, and infectious gastroenteritis. Elevated calprotectin levels can also be found in patients with lesion only in the upper gastrointestinal tract. However, the diagnostic value of calprotectin has never been tested in this setting. The aim of the study is therefore to determine the diagnostic value of fecal calprotectin in patients with diseases of the upper gastrointestinal tract.

Conditions

  • Peptic Esophagitis
  • Peptic Ulcer
  • Functional Dyspepsia
  • Irritable Bowel Syndrome
  • Inflammatory Bowel Diseases

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Christoph Beglinger, Prof. · University Hospital, Basel, Switzerland

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2009-09-30
Completion
2009-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00920400 on ClinicalTrials.gov